VP of Research & Policy, Ewing Marion Kauffman Foundation
Professor of Innovation at The University of Texas at Austin
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
Chairman and CEO, Nanobiosym Diagnostics Inc.
New Paradigms is guided by key individuals from biotech, pharma and the investment community to advance R&D through alternative sources of funding, non-traditional partnering strategies and innovative approaches to drug approval for the successful commercialization of new therapies. The conference is backed by an exceptionally distinguished speaking faculty with diverse experience and expertise. Co-located at the same time as the JP Morgan Healthcare event, on-site networking partnering services available to registered attendees.
15 percent off registration fee for Xconomy readers with code XCNP.
Information and registration at http://www.theconferenceforum.org/NewParadigms-Agenda-DayOne.html